THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained in it is incomplete and is subject to change. This Web Proof Information Pack must be read in conjunction with the section headed ‘‘Warning’’ on the cover of this Web Proof Information Pack. DIRECTORS AND SENIOR MANAGEMENT DIRECTORS Our Board of Directors currently consists of seven Directors, comprised of one executive Director, three non-executive Directors and three independent non-executive Directors. The following table sets forth information regarding the Directors. Date of Appointment Name Age Position as Director Mr. JIANG Liwei (姜黎威) 46 Chief executive officer and executive Director(1) June 21, 2013 Mr. LIN Junshan (林君山) 51 Chairman and non-executive Director(2) June 21, 2013 Ms. Yue’e ZHANG (張月娥) 50 Non-executive Director(2) May 13, 2011 Mr. FENG Dai (馮岱) 38 Non-executive Director(2) June 21, 2013 Mr. ZHANG Xingdong (張興棟) 75 Independent non-executive Director(2) October 14, 2013 Mr. CHEN Geng (陳庚) 42 Independent non-executive Director(2) October 14, 2013 Mr. WANG Xiaogang (王小剛) 40 Independent non-executive Director(2) October 14, 2013 (1) Our executive Director oversees our Group’s overall corporate strategies and management. (2) Our non-executive Directors and independent non-executive Directors are responsible for our Group’s compliance, corporate governance, development and business strategies. Save as disclosed below, there are no other matters concerning each of the Directors’ appointment that need to be brought to the attention of our Shareholders and there are no other matters which shall be disclosed pursuant to [.]. Executive Director Mr. JIANG Liwei (姜黎威), aged 46, is our chief executive officer and executive Director. He is primarily responsible for the overall corporate strategies and management of our Group. Mr. JIANG has 20 years of management experience in the medical device industry. Prior to joining our Group in February 2013, Mr. JIANG was the head of China for Biomet China Co., Ltd. (邦美(上海)商貿有限公司) from 2008 to 2013 and the general manager of Trauson Medical Device (China) Co., Ltd. (創生醫療器械(中國)有限公司) from 2005 to 2008. He also held various management positions with Zimmer (Shanghai) Medical International Trading Co., Ltd. (捷邁(上海)醫療國際貿易有限公司) from 1999 to 2005 and Smith & Nephew Medical (Shanghai) Limited (施樂輝醫用產品國際貿易(上海)有限公司) from 1997 to – 181 – THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained in it is incomplete and is subject to change. This Web Proof Information Pack must be read in conjunction with the section headed ‘‘Warning’’ on the cover of this Web Proof Information Pack. DIRECTORS AND SENIOR MANAGEMENT 1999. Mr. JIANG was a resident doctor for a few years upon graduation from Shanghai Second Medical University (上海第二醫科大學) (now School of Medicine, Shanghai Jiaotong University (上海交通大學醫學院)) with a bachelor’s degree in clinical medicine in July 1991. Mr. JIANG has not been a director of any publicly listed company during the three years preceding the date of this document. Non-executive Directors Mr. LIN Junshan (林君山), aged 51, is our chairman and a non-executive Director. Mr. LIN joined our Group as a director of Walkman Biomaterial in April 2010, and has been a director of PWM Investment since December 2010, a director of PW Medtech (Beijing) since February 2013 and the chairman of Fert Technology since April 2013. Before joining our Group, Mr. LIN was a chief engineer and professorate senior engineer of CSR Qingdao Sifang Locomotive & Rolling Stock Co., Ltd. (南車青島四方機車車輛股份有限公司) from January 2007 to June 2013. After graduation from Xi’an Jiaotong University (西安交通大學) with a doctorate degree in materials science and engineering in March 1990, Mr. LIN held various research positions in Shanghai Jiaotong University (上海交通大學), Osaka University (Japan) and Hitachi Mechanical Engineering Research Laboratory (now Hitachi Research Laboratory), Hitachi Ltd. from April 1990 to December 2006. Mr. LIN has not been a director of any publicly listed company during the three years preceding the date of this document. Ms. Yue’eZHANG(張月娥), aged 50, is a non-executive Director. She is also the executive director of Cross Mark since February 2007 and a director of PWM Investment since December 2010. In addition to her roles with our Group, Ms. ZHANG currently serves as the general manager, senior engineer and executive director of WP Medical Technologies, Inc. Ms. ZHANG has worked in the medical device industry for approximately 20 years and has accumulated considerable experience in product design, research and development, and management and investment. Ms. ZHANG graduated from Xi’an Jiaotong University (西安交 通大學) with a bachelor’s degree in materials science and engineering in July 1985, and later received two master’s degrees relating to material sciences and management from Xi’an University of Technology (西安理工大學) and Florida International University in July 1988 and April 1996, respectively. WP Medical Technologies Inc., where Ms. ZHANG has been serving in multiple roles, is an investment holding company and a founding shareholder of Lepu Medical Technology (Beijing) Co., Ltd. (樂普(北京)醫療器械股份有限公司), or Lepu Medical. Lepu Medical, [.] on the Shenzhen Stock Exchange (stock code: 300003), is a high-tech medical device developer and manufacturer with a focus on cardiac therapy, whose business does not represent a competing business of our Group. Ms. ZHANG and her husband, Mr. PU Zhongjie, were among the early founders of Lepu Medical. – 182 – THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained in it is incomplete and is subject to change. This Web Proof Information Pack must be read in conjunction with the section headed ‘‘Warning’’ on the cover of this Web Proof Information Pack. DIRECTORS AND SENIOR MANAGEMENT Ms. ZHANG has not been a director of any publicly listed company during the three years preceding the date of this document. Ms. ZHANG is Ms. Yufeng LIU’sdaughter. Mr. FENG Dai (馮岱), aged 38, is a non-executive Director. He is also the chairman of Walkman Biomaterial since January 2013, a director of PWM Investment since December 2010 and a director of Fert Technology since December 2012. He also served as a director of Walkman Biomaterial from October 2010 to February 2012. In addition to his roles with our Group, Mr. FENG is currently a managing director of Warburg Pincus Asia LLC and a director of EA Inc. (時代天使生物科技有限公司), Beijing Amcare Women’s and Children’s Hospital Co., Ltd. (北京美中宜和婦兒醫院有限公司) and Lepu Medical. Prior to joining Warburg Pincus Asia LLC, Mr. FENG commenced his career with Goldman Sachs (Asia) LLC as an analyst in 1997 and an associate in 2003. Mr. FENG graduated from Harvard University with a bachelor’s degree in electrical engineering in June 1997. Independent Non-executive Directors Mr. ZHANG Xingdong (張興棟), aged 75, is an independent non-executive Director. He is also an independent non-executive director of LifeTech Scientific Corporation, a company listed on the Stock Exchange (stock code: 8122), since 2011. Mr. ZHANG is currently a professor at Sichuan University (四川大學), an Academician of the Chinese Academy of Engineering (中國工程院院士) and the president of the Chinese Society for Biomaterials (中國生物材料學會理事長). He has more than 10 honorary titles, including the International Union of Societies of Biomaterials Science and Engineering (國際生物材料委員 會), council member of the Tissue Engineering and Regenerative Medicine International Society (Asia Pacific Chapter) (國際組織工程與再生醫學學會大陸(亞太)理事會), adviser in the Science and Technology Advisory Group for the People’s Government of Sichuan Province, chairman of National Technical Committee 248 on Biological Evaluation on Medical Device of Standardization, and chairman of National Technical Committee on Dental Materials and Devices of Standardization. Mr. ZHANG has conducted in-depth research in artificial bone and coatings which is widely recognized and applied in the PRC medical equipment. His research has received numerous awards, including the National Science and Technology Progress Award. Mr. ZHANG graduated from Sichuan University with a bachelor’s degree in solid state physics in 1960. Mr. CHEN Geng (陳庚), aged 42, is an independent non-executive Director. Mr. CHEN is the vice president of EC-Founder (Holdings) Company Limited, a company listed on the Stock Exchange (stock code: 0618), since May 2013. He also served as its executive president from 2005 to 2006 and executive director from 2006 to May 2013. He was also an executive director of Founder Holdings Limited, a company listed on the Stock Exchange (stock code: 0418), from 2006 to 2011, the vice president of New Auto Group (新奧特集團) from 2004 to 2005 and had worked in various investment firms in China, garnering extensive experience in finance and management. Mr. CHEN has obtained the qualification of senior economist (高級 經濟師) from China State Construction Engineering Corporation (中國建築工程總公司)in – 183 – THIS WEB PROOF INFORMATION PACK IS IN DRAFT FORM. The information contained in it is incomplete and is subject to change. This Web Proof Information Pack must be read in conjunction with the section headed ‘‘Warning’’ on the cover of this Web Proof Information Pack. DIRECTORS AND SENIOR MANAGEMENT October 2010. He graduated from Northwest University (西北大學) with a bachelor’sdegreein administrative management in July 1993 and later received an EMBA degree from Guanghua School of Management, Peking University (北京大學光華管理學院) in January 2005. Mr. WANG Xiaogang (王小剛), aged 40,